Trials / Completed
CompletedNCT02368483
Conservative Treatment in Patients With Symptomatic Femoroacetabular Impingement
The Effectiveness of Neuromuscular Training of the Lower Limb Muscles in Reducing the Hip Symptoms in Patients With Symptomatic Femoroacetabular Impingement: a Prospective Intervention Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Schulthess Klinik · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-group, prospective, intervention study. A total of 30 participants with unilateral symptomatic femoroacetabular impingement will be included into the study. The intervention consists in neuromuscular training for the lower limb muscles (12 weeks, 2 times/week supervised training, 2 times/week home training). The training includes physical exercises routinely used worldwide in clinical settings. No control intervention group was included into the study because nowadays there is no standard conservative treatment for patients with symptomatic femoroacetabular impingement. Assessments will be performed at (1) baseline, (2) mid-intervention, (3) end-intervention, and (4) follow-up. Clinical, functional, neuromuscular and self-reported parameters will be collected during assessments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Neuromuscular training | Neuromuscular training for the hip and lower limb muscles.The training program is divided into 3 phases, and includes specific exercises for improving the hip range of motion, muscle strength of the hip and lower limb muscles, as well as the trunk stability and coordination. The intervention lasts 12 weeks. Patients will train 2 times/week with a physical therapist and 2 times/weeks alone at home. |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2017-03-01
- Completion
- 2017-03-01
- First posted
- 2015-02-23
- Last updated
- 2019-06-18
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02368483. Inclusion in this directory is not an endorsement.